AstraZeneca’s $1.2 Billion Acquisition of Gracell Biotechnologies

Freshfields Bruckhaus Deringer and Maples Group are advising AstraZeneca on the transaction, and Cooley and Harney Westwood & Riegels are advising Gracell Biotechnologies.AstraZeneca announced it has…

This content is for Standard 1 Year members only.
Login Join Now
Avatar

Author: Leila Ahmed

This content is for Standard 1 Year members only.
Login Join Now